These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25934551)

  • 1. Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011.
    Kasai A; Ogihara S; Yamada K; Tanimichi Y; Nishiyama H; Saito R
    J Med Microbiol; 2015 Jul; 64(7):708-713. PubMed ID: 25934551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of macrolide-lincosamide resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Nishiyama H; Okamura N
    J Med Microbiol; 2012 Oct; 61(Pt 10):1435-1438. PubMed ID: 22820696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility and mechanisms of high-level macrolide resistance in clinical isolates of Moraxella nonliquefaciens.
    Nonaka S; Matsuzaki K; Kazama T; Nishiyama H; Ida Y; Koyano S; Sonobe K; Okamura N; Saito R
    J Med Microbiol; 2014 Feb; 63(Pt 2):242-247. PubMed ID: 24196134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
    Liu Y; Xu H; Xu Z; Kudinha T; Fan X; Xiao M; Kong F; Sun H; Xu Y
    Microb Drug Resist; 2015 Oct; 21(5):507-11. PubMed ID: 25923017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and impact of macrolide antibiotics on Moraxella catarrhalis in the upper and lower airways of children with chronic endobronchial suppuration.
    Hare KM; Seib KL; Chang AB; Harris TM; Spargo JC; Smith-Vaughan HC
    J Med Microbiol; 2019 Aug; 68(8):1140-1147. PubMed ID: 31274402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid assay of A2058T-mutated 23S rRNA allelic profiles associated with high-level macrolide resistance in Moraxella catarrhalis.
    Saito R; Kasai A; Ogihara S; Yamada K; Tao K
    J Med Microbiol; 2015 Sep; 64(9):990-992. PubMed ID: 26296581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.
    Gibreel A; Kos VN; Keelan M; Trieber CA; Levesque S; Michaud S; Taylor DE
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2753-9. PubMed ID: 15980346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
    Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.
    Descours G; Ginevra C; Jacotin N; Forey F; Chastang J; Kay E; Etienne J; Lina G; Doublet P; Jarraud S
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.
    Doern GV; Brueggemann AB; Pierce G; Hogan T; Holley HP; Rauch A
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2884-6. PubMed ID: 9124860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China.
    Liu Y; Zhao C; Zhang F; Chen H; Chen M; Wang H
    Microb Drug Resist; 2012 Aug; 18(4):417-26. PubMed ID: 22394083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mechanism responsible for high-level macrolide resistance in
    Kasai A; Ohta A; Maeda Y; Yamada K; Tao K; Saito R
    Infect Drug Resist; 2018; 11():2137-2140. PubMed ID: 30464556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing].
    Yang H; Shen XZ; Wang YH; Yuan L; Yu SJ; Yang YH
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):936-9. PubMed ID: 15733368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of low-level fluoroquinolone resistance in clinical isolates of Moraxella catarrhalis.
    Yamada K; Saito R
    J Med Microbiol; 2014 Aug; 63(Pt 8):1066-1070. PubMed ID: 24850882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
    Schlegel L; Merad B; Rostane H; Broc V; Bouvet A
    Clin Microbiol Infect; 2001 Jul; 7(7):362-6. PubMed ID: 11531981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.